Posts

Posts Shortcodes

You can show the posts with Porto Blog, Porto Recent Posts shortcodes.


Recent

Provider Alert!

Provider Alert! Change in Preferred Drug List Status for Glucocorticoids, Inhaled Drug Class

Date: December 8, 2023 Attention: Providers Effective date: December 15, 2023 Call to action: Effective December 15, 2023, the Texas Health and Human... read more

Provider Alert!

Provider Alert! Important Dates: Complete EVV Visit Maintenance and Submit VMURs Before Losing Access

Date: December 8, 2023 Attention: STAR Kids Providers/Consumer Directed Services employers and FMSA Providers Call to action: Texas Children’s Health Plan (TCHP)... read more

Provider Alert!

Provider Alert! Follow-Up Care for Children Prescribed ADHD Medication (ADD, ADD-E)

Date: December 7, 2023 Attention: All Providers Call to Action: Texas Children Health Plan (TCHP) would like to remind providers to continue to... read more

Provider Alert!

Provider Alert! Coverage of Vyjuvek (procedure code J3401) Begins January 2024; Prior Authorization Effective February 2024

Date: December 6, 2023 Attention: All Providers Prior Authorization Effective Date: February 1, 2024 Call to action: Texas Children’s Health Plan (TCHP) would... read more

Provider Alert!

Provider Alert! Coverage of Roctavian (procedure code J1412) Begins January 2024; Prior Authorization Effective February 2024

Date: December 6, 2023 Attention: All Providers Prior Authorization Effective Date: February 1, 2024 Call to action: Texas Children’s Health Plan (TCHP) would... read more

Provider Alert!

Provider Alert! Coverage of Adstiladrin (procedure code J9029) Begins January 2024; Prior Authorization Effective February 2024

Date: December 6, 2023 Attention: All Providers Prior Authorization Effective Date: February 1, 2024 Call to action: Texas Children’s Health Plan (TCHP) would... read more

Provider Alert!

Provider Alert! Fee-for-Services (FFS) Telephone (Audio-Only) Telemedicine Services for Non-Behavioral Health Conditions

Date: December 7, 2023 Attention: All Providers Effective for dates of service on or after November 1, 2023 Call to action: The purpose... read more

Provider Alert! Coverage of Commercialized COVID-19 Vaccines Begins as a Pharmacy Benefit

Effective Dates: As of September 11, 2023 & October 3, 2023 Date: December 4, 2023 Attention: All Providers Call to action: Texas Children’s... read more


Timeline

December 2023

Provider Alert!

Provider Alert! Change in Preferred Drug List Status for Glucocorticoids, Inhaled Drug Class

Date: December 8, 2023 Attention: Providers Effective date: December 15, 2023 Call to action: Effective December 15, 2023, the Texas Health and Human Services (HHS) removed non-preferred status from generic fluticasone hydrofluoroalkane (HFA) and brand Qvar products on the preferred drug list. This is in response to the discontinuation of the product by the manufacturer. The preferred status of the brand name Flovent HFA and Flovent Diskus will not change to allow for any remaining stock to be used. How this impacts providers: The change...

Provider Alert!

Provider Alert! Important Dates: Complete EVV Visit Maintenance and Submit VMURs Before Losing Access

Date: December 8, 2023 Attention: STAR Kids Providers/Consumer Directed Services employers and FMSA Providers Call to action: Texas Children’s Health Plan (TCHP) would like to remind program providers, financial management services agencies (FMSAs) and Consumer Directed Services (CDS) employers who are transitioning to HHAeXchange, are responsible for completing all required visit maintenance, including Visit Maintenance Unlock Requests (VMURs), in their current EVV vendor system, DataLogic/Vesta or First Data/AuthentiCare by Dec. 22, 2023. Any visits for dates of service on or after the program providers,...


Grid

Provider Alert!

Provider Alert! Change in Preferred Drug List Status for Glucocorticoids, Inhaled Drug Class

Date: December 8, 2023 Attention: Providers Effective date: December 15, 2023 Call to action: Effective December 15, 2023, the Texas Health and Human Services (HHS) removed non-preferred status from generic fluticasone hydrofluoroalkane (HFA) and brand Qvar products on the preferred drug list. This is in response to the discontinuation of the product by the manufacturer. The preferred status of the brand name Flovent HFA and Flovent Diskus will not change to allow for any remaining stock to be used. How this impacts providers: The change...

Provider Alert!

Provider Alert! Important Dates: Complete EVV Visit Maintenance and Submit VMURs Before Losing Access

Date: December 8, 2023 Attention: STAR Kids Providers/Consumer Directed Services employers and FMSA Providers Call to action: Texas Children’s Health Plan (TCHP) would like to remind program providers, financial management services agencies (FMSAs) and Consumer Directed Services (CDS) employers who are transitioning to HHAeXchange, are responsible for completing all required visit maintenance, including Visit Maintenance Unlock Requests (VMURs), in their current EVV vendor system, DataLogic/Vesta or First Data/AuthentiCare by Dec. 22, 2023. Any visits for dates of service on or after the program providers,...

Provider Alert!

Provider Alert! Follow-Up Care for Children Prescribed ADHD Medication (ADD, ADD-E)

Date: December 7, 2023 Attention: All Providers Call to Action: Texas Children Health Plan (TCHP) would like to remind providers to continue to take measures to ensure that your patients with an Attention Deficit Hyperactivity Disorder (ADHD) diagnosis are receiving excellent care. ADHD is one of the most common behavioral health disorders in children (National Committee for Quality Assurance, 2023; Visser et al., 2014). To ensure that medication is prescribed and managed correctly, it is important that prescribing providers carefully monitor their pediatric...


Medium

Provider Alert! Change in Preferred Drug List Status for Glucocorticoids, Inhaled Drug Class

Date: December 8, 2023 Attention: Providers Effective date: December 15, 2023 Call to action: Effective December 15, 2023, the Texas Health and Human Services (HHS) removed non-preferred status from generic fluticasone hydrofluoroalkane (HFA) and brand Qvar products on the preferred drug list. This is in response to the discontinuation of the product by the manufacturer. The preferred status of the brand name Flovent HFA and Flovent Diskus will not change to allow for any remaining stock to be used. How this impacts providers: The change...

Provider Alert! Important Dates: Complete EVV Visit Maintenance and Submit VMURs Before Losing Access

Date: December 8, 2023 Attention: STAR Kids Providers/Consumer Directed Services employers and FMSA Providers Call to action: Texas Children’s Health Plan (TCHP) would like to remind program providers, financial management services agencies (FMSAs) and Consumer Directed Services (CDS) employers who are transitioning to HHAeXchange, are responsible for completing all required visit maintenance, including Visit Maintenance Unlock Requests (VMURs), in their current EVV vendor system, DataLogic/Vesta or First Data/AuthentiCare by Dec. 22, 2023. Any visits for dates of service on or after the program providers,...


Large

Provider Alert!

Provider Alert! Change in Preferred Drug List Status for Glucocorticoids, Inhaled Drug Class

Date: December 8, 2023 Attention: Providers Effective date: December 15, 2023 Call to action: Effective December 15, 2023, the Texas Health and Human Services (HHS) removed non-preferred status from generic fluticasone hydrofluoroalkane (HFA) and brand Qvar products on the preferred drug list. This is in response to the discontinuation of the product by the manufacturer. The preferred status of the brand name Flovent HFA and Flovent Diskus will not change to allow for any remaining stock to be used. How this impacts providers: The change...

Provider Alert!

Provider Alert! Important Dates: Complete EVV Visit Maintenance and Submit VMURs Before Losing Access

Date: December 8, 2023 Attention: STAR Kids Providers/Consumer Directed Services employers and FMSA Providers Call to action: Texas Children’s Health Plan (TCHP) would like to remind program providers, financial management services agencies (FMSAs) and Consumer Directed Services (CDS) employers who are transitioning to HHAeXchange, are responsible for completing all required visit maintenance, including Visit Maintenance Unlock Requests (VMURs), in their current EVV vendor system, DataLogic/Vesta or First Data/AuthentiCare by Dec. 22, 2023. Any visits for dates of service on or after the program providers,...


Large Alt

Provider Alert!

Provider Alert! Change in Preferred Drug List Status for Glucocorticoids, Inhaled Drug Class

Date: December 8, 2023 Attention: Providers Effective date: December 15, 2023 Call to action: Effective December 15, 2023, the Texas Health and Human Services (HHS) removed non-preferred status from generic fluticasone hydrofluoroalkane (HFA) and brand Qvar products on the preferred drug list. This is in response to the discontinuation of the product by the manufacturer. The preferred status of the brand name Flovent HFA and Flovent Diskus will not change to allow for any remaining stock to be used. How this impacts providers: The change...

Read more...
Provider Alert!

Provider Alert! Important Dates: Complete EVV Visit Maintenance and Submit VMURs Before Losing Access

Date: December 8, 2023 Attention: STAR Kids Providers/Consumer Directed Services employers and FMSA Providers Call to action: Texas Children’s Health Plan (TCHP) would like to remind program providers, financial management services agencies (FMSAs) and Consumer Directed Services (CDS) employers who are transitioning to HHAeXchange, are responsible for completing all required visit maintenance, including Visit Maintenance Unlock Requests (VMURs), in their current EVV vendor system, DataLogic/Vesta or First Data/AuthentiCare by Dec. 22, 2023. Any visits for dates of service on or after the program providers,...

Read more...

Full

Provider Alert!

Provider Alert! Change in Preferred Drug List Status for Glucocorticoids, Inhaled Drug Class

Date: December 8, 2023 Attention: Providers Effective date: December 15, 2023 Call to action: Effective December 15, 2023, the Texas Health and Human Services (HHS) removed non-preferred status from generic fluticasone hydrofluoroalkane (HFA) and brand Qvar products on the preferred drug list. This is in response to the discontinuation of the product by the manufacturer. The preferred status of the brand name Flovent HFA and Flovent Diskus will not change to allow for any remaining stock to be used. How this impacts providers: The change...

Read more...
Provider Alert!

Provider Alert! Important Dates: Complete EVV Visit Maintenance and Submit VMURs Before Losing Access

Date: December 8, 2023 Attention: STAR Kids Providers/Consumer Directed Services employers and FMSA Providers Call to action: Texas Children’s Health Plan (TCHP) would like to remind program providers, financial management services agencies (FMSAs) and Consumer Directed Services (CDS) employers who are transitioning to HHAeXchange, are responsible for completing all required visit maintenance, including Visit Maintenance Unlock Requests (VMURs), in their current EVV vendor system, DataLogic/Vesta or First Data/AuthentiCare by Dec. 22, 2023. Any visits for dates of service on or after the program providers,...

Read more...

Leave a Reply